MedPath

Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria

Recruiting
Conditions
Colorectal Cancer
Breast Cancer
Registration Number
NCT05044689
Lead Sponsor
Obafemi Awolowo University Teaching Hospital
Brief Summary

This project is a case-control study which seeks to identify modifiable risk factors for breast and colorectal cancer in Nigeria. Both cases and controls will be required to complete a risk factor questionnaire which contains information about their diet, physical activity, past medical history and life style factors. They will also be required to provide information on their body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water percentage.

Based on the existing ARGO platform where a current colorectal cancer study is going on, approximately 400 patients with a prior diagnosis or a new diagnosis will be recruited into this study. Comparatively, we will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
800
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development and Validation of Questionnaire For Assessing Modifiable Risk Factors for Cancer in Sub-Saharan Africa2 years
Determination of Novel Modifiable Cancer Risk Factors in a Nigerian Population2 years

We will determine the presence of established, plausible, and novel cancer risk factors in cases (n=400) and controls (n=400) in Nigeria

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Obafemi Awolowo University Teaching Hospitals

🇳🇬

Ile Ife, Osun, Nigeria

Obafemi Awolowo University Teaching Hospitals
🇳🇬Ile Ife, Osun, Nigeria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.